Rao, T. N., Hansen, N., Hilfiker, J., Rai, S., Majewska, J-M., Leković, D., Gezer, D., Andina, N., Galli, S., Cassel, T., Geier, F., Delezie, J., Nienhold, R., Hao-Shen, H., Beisel, C.
, Di Palma, S., Dimeloe, S., Trebicka, J., Wolf, D., ... Skoda, R. C. (2019).
JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms.
Blood,
134(21), 1832-1846.
https://doi.org/10.1182/blood.2019000162